AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 89 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,532,000 | +22.2% | 440,000 | +95.6% | 0.00% | +50.0% |
| Q2 2023 | $3,708,000 | +997.0% | 225,000 | +233.4% | 0.00% | – |
| Q3 2022 | $338,000 | +10.8% | 67,482 | -46.0% | 0.00% | – |
| Q2 2022 | $305,000 | -87.0% | 125,000 | -63.6% | 0.00% | -100.0% |
| Q1 2022 | $2,345,000 | -15.5% | 343,407 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $2,775,000 | -17.5% | 343,407 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $3,365,000 | +3.9% | 343,407 | -28.6% | 0.00% | 0.0% |
| Q2 2021 | $3,238,000 | -16.2% | 481,194 | +12.5% | 0.00% | 0.0% |
| Q1 2021 | $3,866,000 | +35.3% | 427,676 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,857,000 | +27.4% | 427,676 | -3.9% | 0.00% | 0.0% |
| Q3 2020 | $2,243,000 | -35.1% | 445,057 | +4.1% | 0.00% | -33.3% |
| Q2 2020 | $3,456,000 | -26.0% | 427,676 | -27.3% | 0.00% | -25.0% |
| Q1 2020 | $4,671,000 | +5.2% | 588,307 | 0.0% | 0.00% | +33.3% |
| Q4 2019 | $4,441,000 | +81.5% | 588,307 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $2,447,000 | +43.6% | 588,307 | -0.2% | 0.00% | +100.0% |
| Q2 2019 | $1,704,000 | +97.2% | 589,676 | -1.8% | 0.00% | 0.0% |
| Q1 2019 | $864,000 | +1316.4% | 600,700 | +2412.9% | 0.00% | – |
| Q4 2018 | $61,000 | -98.3% | 23,905 | -97.1% | 0.00% | -100.0% |
| Q3 2018 | $3,570,000 | -67.4% | 813,261 | -54.5% | 0.00% | -66.7% |
| Q2 2018 | $10,952,000 | +21.0% | 1,786,893 | +43.9% | 0.00% | -25.0% |
| Q1 2018 | $9,049,000 | +0.0% | 1,241,432 | +12.5% | 0.00% | -33.3% |
| Q4 2017 | $9,045,000 | -22.5% | 1,103,182 | -0.8% | 0.01% | -25.0% |
| Q3 2017 | $11,678,000 | -31.3% | 1,112,342 | -27.8% | 0.01% | -33.3% |
| Q2 2017 | $16,991,000 | +48.5% | 1,540,546 | +30.3% | 0.01% | +50.0% |
| Q1 2017 | $11,443,000 | – | 1,182,210 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |